LogiPharma USA 2021

July 20 - 21, 2021

Online (ET)


Enhanced Due Diligence: Your Prescription for Mitigating Risk in the Pharma Supply Chain

Faced with increasing globalization and supply chain complexity, pharmaceutical companies have the daunting task of managing risks – ranging from counterfeiting to piracy – that could potentially threaten patient safety. What’s more, the pharmaceutical industry is not immune to the impact of stricter laws and sanctions to counter bribery and corruption. View this webinar to learn about:

  • Anti-money laundering, anti-bribery and corruption enforcement trends and regulator expectations
  • The impact that enforcement actions have already had within the Pharma industry
  • Why a healthy due-diligence strategy is the best approach to reducing regulatory risk

Keynote Speaker:

  • Mark Dunn, Segment Leader for Entity Due Diligence & Monitoring at Lexis Nexis

Our Sponsors: